Evidence map›Paper›PMID 38427230›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Quantification of Neuroinflammatory Markers in Blood, Cerebrospinal Fluid, and Resected Brain Samples Obtained from Patients.

Arpna Srivastava, Aparna Banerjee Dixit, Manjari Tripathi, P Sarat Chandra, Jyotirmoy Banerjee

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Arpna SrivastavaDepartment of Neurology, AIIMS, New Delhi, India.
Aparna Banerjee DixitDr B R Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, India.
Manjari TripathiDepartment of Neurology, AIIMS, New Delhi, India.
P Sarat ChandraDepartment of Neurosurgery, AIIMS, New Delhi, India.
Jyotirmoy BanerjeeDepartment of Biophysics, AIIMS, New Delhi, India. jyotirmoy@aiims.edu.
All India Institute of Medical Sciences Raipur · INAll India Institute of Medical Sciences · INAll India Institute of Medical Sciences Bhopal · INUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytokines have the potential to be the ideal biomarkers to track the onset and progression of immune-mediated diseases, study the development of novel therapeutic strategies, and they can serve as outcome parameters due to their crucial role in the regulation of immune and inflammatory responses. It is vital to keep track of the entire cytokine spectrum due to the complex interactions, pleiotropic effects, and redundancy in the cytokine network. The multiplex immunoassay (MIA) is, therefore, the best method for achieving that goal. This chapter addresses the key methodological processes of this technique, such as sample preparation, antibody coupling to beads, and assay procedure.

Indexed as

AntibodiesCytokinesBiomarkersBrainExtracellular SpaceHumansImmunoassayAntibodiesBiomarkersCytokinesBiomarkersCytokinesELISAMultiplex immunoassayNeuroinflammation

Identifiers

PMID38427230
OpenAlexW4392394619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.